Cancer Treatment News and Research

RSS

New class of nontoxic cancer treatments

A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report today.

2 May 2007

Influence of the cellular microenvironment on breast cancer

This month The American Journal of Pathology highlights the influence of the cellular microenvironment on breast cancer by promoting three articles from the current issue.

27 Apr 2007

No evidence that antioxidant supplements interfere with therapeutic effects of chemotherapy agents

There is no evidence that antioxidant supplements interfere with the therapeutic effects of chemotherapy agents, according to a recent systematic review of the use of antioxidants during chemotherapy, available in the May, 2007 issue of the journal Cancer Treatment Reviews.

25 Apr 2007

Gold nanoparticles for early detection of cancer

By attaching gold nanoparticles - like tiny balls or rods- to cancer cells, earlier detection will be possible.

24 Apr 2007

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.

24 Apr 2007

Developing world can expect a 'pandemic of cancer' by 2020

The developing world is expected to account for more than half of all cancer cases in the world by 2020 say medical experts.

23 Apr 2007

Potential new test for breast cancer patients for abnormal reactions to radiotherapy

Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment.

20 Apr 2007

Prostate cancer treatment decisions can be complicated

For many men with early-stage prostate cancer, sorting out the treatment options can be overwhelming.

20 Apr 2007

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma

Genta Incorporated has announced that the Company will conduct a new randomized controlled Phase 3 trial of its lead anticancer product, Genasense (oblimersen sodium) Injection, in patients with advanced melanoma.

19 Apr 2007

New discoveries about stem cells in leukemia, breast and colon cancer

Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. With each new study, scientists are learning more about cancer-initiating properties of stem cells at organ sites and throughout the body.

19 Apr 2007

Side-effects of treatment for localized prostate cancer

It seems plausible that prostate cancer (CaP) patients might value health states associated with side-effects of treatment for localized CaP as less detrimental than men with no CaP.

17 Apr 2007

Lower educational level makes some men more vulnerable to the effects of prostate cancer

Among men who have received similar treatments for prostate cancer, those with less education , particularly those who did not graduate from high school , experience a significant drop in their quality of life after treatment compared with men who have more education, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC).

15 Apr 2007

Oncolytics Biotech to proceed with phase II Sarcoma trial

Oncolytics Biotech has announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN in patients with various sarcomas that have metastasized to the lung.

11 Apr 2007

Aflac expands partnership with American Association for Cancer Research

Recognizing the growing need to nurture the next generation of cancer researchers, Aflac has expanded its generous commitment to the American Association for Cancer Research by sponsoring the new AACR-Aflac Career Development Award for Pediatric Cancer Research, in addition to renewing its support for the AACR Associate Member Council and the AACR-Aflac Scholar-in-Training Awards, now in their 10th year.

11 Apr 2007

Method for making new molecules based on flavonoids - implications for cancer therapeutics

You've heard of them -- the good-for-your-health compounds found in plants that we enjoy in red wine, dark chocolate, green tea and citrus fruits.

5 Apr 2007

Newmarket, Ontario to establish world-class cancer centre

Princess Margaret Hospital (PMH) will share its latest knowledge, research in cancer care, and expertise to assist Southlake Regional Health Centre (Southlake) in establishing a world-class cancer centre through a formal affiliation between a world leader in cancer care and the newly established cancer program in the Newmarket-based hospital.

5 Apr 2007

Lack of Olig1 protein in lung tumors may increase risk of death

A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.

2 Apr 2007

DNA repair runs by the biological clock

No sooner have the clocks gone forward than scientists have shed new light on the link between our biological clocks and DNA damage repair processes, essential in protecting our cells from cancer.

27 Mar 2007

Blood pressure drug shows potential as lung cancer treatment

A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine.

19 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007